Exome Asset Management’s Viridian Therapeutics VRDN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-217,294	Closed	-$2.93M	–	77
2025 Q1	$2.93M	Buy	+217,294	New	+$2.93M	2.6%	14
2024 Q4	–	Sell	-174,400	Closed	-$3.97M	–	80
2024 Q3	$3.97M	Buy	+174,400	New	+$3.97M	2.68%	12